Petros Pharmaceuticals, Inc.

PTPI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$14-$8-$20-$9
Dep. & Amort.$3$3$6$7
Deferred Tax$0$0$0-$9
Stock-Based Comp.$0$0$1$1
Change in WC$5$1-$3-$2
Other Non-Cash$4-$4$4$0
Operating Cash Flow-$3-$8-$13-$12
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.-$1-$1-$2-$7
Stock Issued$0$0$0$22
Stock Repurch.$0$0$0$0
Dividends Paid-$1,293$0$0$0
Other Fin. Act.$1,287$13$0$4
Financing Cash Flow-$7$12-$2$19
Forex Effect$0$0$0$0
Net Chg. in Cash-$10$4-$14$7
Supplemental Information
Beg. Cash$13$9$24$17
End Cash$4$13$9$24
Free Cash Flow-$3-$8-$13-$12
Petros Pharmaceuticals, Inc. (PTPI) Financial Statements & Key Stats | AlphaPilot